Sarcopenia is a Predictor of Postoperative Respiratory Complications in Patients with Esophageal Cancer

Annals of Surgical Oncology

Volumn 22, Issue 13, 2015, Pages 4432-4437

  Ida, Satoshi ^a,b   Watanabe, Masayuki ^b   Yoshida, Naoya ^a   Baba, Yoshifumi ^a   Umezaki, Naoki ^a   Harada, Kazuto ^a   Karashima, Ryuichi ^a   Imamura, Yu ^a   Iwagami, Shiro ^a   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; SERUM ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANASTOMOSIS LEAKAGE; ARTICLE; BIOELECTRICAL IMPEDANCE ANALYSIS; BODY MASS; BODY WEIGHT; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CARDIOVASCULAR DISEASE; CHEMORADIOTHERAPY; CONTROLLED STUDY; EMPYEMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPEDANCE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PNEUMONIA; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; RISK FACTOR; SARCOPENIA; SKELETAL MUSCLE; SURGICAL INFECTION; THIN LAYER CHROMATOGRAPHY; THORAX SURGERY; ADVERSE EFFECTS; CARCINOMA, SQUAMOUS CELL; COMPLICATION; ESOPHAGEAL NEOPLASMS; FOLLOW UP; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY;

AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SARCOPENIA;

EID: 84947128519     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-015-4559-3     Document Type: Article

References (31)

1. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349:2241–52.
2. Gertler R, Stein HJ, Langer R, Nettelmann M, Schuster T, et al. Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee staging system. Ann Surg. 2011;253:689–98.
3. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg. 1980;67:381–90.
4. Wu PC, Posner MC. The role of surgery in the management of oesophageal cancer. Lancet Oncol. 2003;4:481–8.
5. Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539–47.
6. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9:629–35.
7. Harimoto N, Shirabe K, Yamashita YI, Ikegami T, Yoshizumi T, et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg. 2013;100:1523–30.
8. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, et al. Sarcopenia: European consensus on definition and diagnosis. Report of the European Working Group on sarcopenia in older people. Age Ageing. 2010;39:412–23.
9. Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer. 2012;107:931–36.
10. Masuda T, Shirabe K, Ikegami T, Harimoto N, Yoshizumi T, et al. Sarcopenia is a prognostic factor in living donor liver transplantation. Liver Transpl. 2014;20:401–7.
11. Jaffrin MY, Morel H. Body fluid volumes measurements by impedance: a review of bioimpedance spectroscopy (BIS) and bioimpedance analysis (BIA) methods. Med Eng Phys. 2008;30:1257–69.
12. Kim M, Kim H. Accuracy of segmental multi-frequency bioelectrical impedance analysis for assessing whole-body and appendicular fat mass and lean soft tissue mass in frail women aged 75 years and older. Eur J Clin Nutr. 2013;67:395–400.
13. Kaido T, Mori A, Ogura Y, Ogawa K, Hata K, et al. Pre- and perioperative factors affecting infection after living donor liver transplantation. Nutrition. 2012;28:1104–8.
14. Ida S, Watanabe M, Karashima R, Imamura Y, Ishimoto T, et al. Changes in body composition secondary to neoadjuvant chemotherapy for advanced esophageal cancer are related to the occurrence of postoperative complications after esophagectomy. Ann Surg Oncol. 2014;21:3675–9.
15. Kaido T, Ogawa K, Fujimoto Y, Ogura Y, Hata K, et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant. 2013;13:1549–56.
16. Watanabe M, Nagai Y, Kinoshita K, Saito S, Kurashige J, et al. Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil for patients with node-positive esophageal cancer. Digestion. 2011;83:146–52.
17. Baba Y, Watanabe M, Shigaki H, Iwagami S, Ishimoto T, et al. Negative lymph-node count is associated with survival in patients with resected esophageal squamous cell carcinoma. Surgery. 2013;153:234–41.
18. Yoshida N, Baba Y, Watanabe M, Ida S, Ishimoto T, et al. An original scoring system for predicting postoperative morbidity after esophagectomy for esophageal cancer. Surg Today. 2015;45:346–54.
19. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.
20. Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, et al. Cachexia: a new definition. Clin Nutr. 2008;27:793–99.
21. Koo HK, Park JH, Park HK, Jung H, Lee SS. Conflicting role of sarcopenia and obesity in male patients with chronic obstructive pulmonary disease: Korean National Health and Nutrition Examination Survey. PLoS One. 2014;9:e110448.
22. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen city heart study. Am J Respir Crit Care Med. 2006;173:79–83.
23. Cohen S, Nathan JA, Goldberg AL. Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov. 2014;14:58–74.
24. Bahat G, Tufan A, Ozkaya H, Tufan F, Akpinar TS, et al. Relation between hand grip strength, respiratory muscle strength and spirometric measures in male nursing home residents. Aging Male. 2014;17:136–40.
25. Chen Z, Wang Z, Lohman T, Heymsfield SB, Outwater E, et al. Dual-energy X-ray absorptiometry is a valid tool for assessing skeletal muscle mass in older women. J Nutr. 2007;137:2775–80.
26. Jackson W, Alexander N, Schipper M, Fig L, Feng F, et al. Characterization of changes in total body composition for head and neck cancer patients undergoing chemoradiotherapy using dual-energy X-ray absorptiometry (DEXA). Head Neck. 2014;36:1356–62.
27. Han-Geurts IJ, Hop WC, Tran TC, Tilanus HW. Nutritional status as a risk factor in esophageal surgery. Dig Surg. 2006;23:159–63.
28. Nozoe T, Kimura Y, Ishida M, Saeki H, Korenaga D, et al. Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma. Eur J Surg Oncol. 2002;28:396–400.
29. Kaido T, Uemoto S. Direct segmental multi-frequency bioelectrical impedance analysis is useful to evaluate sarcopenia. Am J Transplant. 2013;13:2506–7.
30. Grotenhuis BA, Wijnhoven BP, Grune F, van Bommel J, Tilanus HW, et al. Preoperative risk assessment and prevention of complications in patients with esophageal cancer. J Surg Oncol. 2010;101:270–8.
31. Ryan AM, Reynolds JV, Healy L, Byrne M, Moore J, et al. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg. 2009;249:355–63.